TIS 0.00% 0.0¢ tissue therapies limited

referral to ema, page-2

  1. 2,243 Posts.
    lightbulb Created with Sketch. 109
    Well, on my rough and ready calcs, they could survive on about $200,000 per month if they stop massive spends on consultants and trials etc.

    They have $5 million in cash, so it looks like we should be ok for a while.

    Would love to know what the "other expenditure" of $135,890 is comprised of. Boston cant be cheap, I guess.

    You would have thought SM might have made an announcement comforting shareholders about our cash position in light of the recent debacle...

 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.